Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-15 Purchase | 2026-07-17 7:29 pm | InMed Pharmaceuticals Inc. | INM | ADAR1 Capital Management LLC Schneeberger Daniel 10% Owner | 1,000 | $1.555 | $1,555 | 801,000 (Indirect) | View |
| 2026-07-14 Purchase | 2026-07-16 9:58 pm | InMed Pharmaceuticals Inc. | INM | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Opportunity Cayman LLC Vivo Opportunity Cayman Fund L.P. 10% Owner | 20,546 | $1.55 | $31,846 | 75,019 (Indirect) | View |
| 2026-06-30 Purchase | 2026-07-02 7:02 pm | InMed Pharmaceuticals Inc. | INM | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Opportunity Cayman LLC Vivo Opportunity Cayman Fund L.P. 10% Owner | 6,551 | $1.5491 | $10,148 | 73,135 (Indirect) | View |
| 2026-05-20 Purchase | 2026-06-10 9:14 pm | InMed Pharmaceuticals Inc. | INM | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Opportunity Cayman LLC Vivo Opportunity Cayman Fund L.P. 10% Owner | 249,227 | $1.5711 | $391,555 | 72,535 (Indirect) | View |
| 2026-05-19 Purchase | 2026-05-21 5:08 pm | InMed Pharmaceuticals Inc. | INM | ADAR1 Capital Management LLC Schneeberger Daniel 10% Owner | 468,551 | $1.54 | $721,548 | 800,000 (Indirect) | View |
| 2024-07-31 Sale | 2024-08-02 4:02 pm | InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Consultant | 240 | $0.1763 | $42 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-06-10 9:14 pm | N/A N/A | InMed Pharmaceuticals Inc. | INM | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Opportunity Cayman Fund L.P. Vivo Opportunity Cayman LLC 10% Owner | 0 | $0 | 541,752 (Indirect) | View |
Ownership | 2026-05-21 4:51 pm | N/A N/A | InMed Pharmaceuticals Inc. | INM | ADAR1 Capital Management LLC Schneeberger Daniel 10% Owner | 0 | $0 | 331,449 (Indirect) | View |
| 2025-12-19 Option Award | 2025-12-19 11:42 am | N/A 2030-12-18 | InMed Pharmaceuticals Inc. | INM | Johnson Shane Aaron Sr VP & General Manager | 8,500 | $0 | 12,400 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 11:42 am | N/A 2030-12-18 | InMed Pharmaceuticals Inc. | INM | Lemerond Nicole Director | 1,750 | $0 | 2,725 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 11:42 am | N/A 2030-12-18 | InMed Pharmaceuticals Inc. | INM | Klompas Neil A Director | 1,750 | $0 | 5,250 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 11:41 am | N/A 2030-12-18 | InMed Pharmaceuticals Inc. | INM | Jagpal Netta Chief Financial Officer | 18,000 | $0 | 24,250 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 11:41 am | N/A 2030-12-18 | InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer | 18,000 | $0 | 25,445 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 11:40 am | N/A 2030-12-18 | InMed Pharmaceuticals Inc. | INM | Bathery John Steven Director | 1,750 | $0 | 5,250 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 11:39 am | N/A 2030-12-18 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 13,000 | $0 | 18,280 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 11:39 am | N/A 2030-12-18 | InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO | 35,000 | $0 | 49,050 (Direct) | View |
| 2025-12-19 Option Award | 2025-12-19 11:38 am | N/A 2030-12-18 | InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director | 1,750 | $0 | 2,711 (Direct) | View |
| 2025-12-15 Expired | 2025-12-17 12:20 pm | 2020-12-16 2025-12-15 | InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director | 14 | $0 | 961 (Direct) | View |
| 2025-12-15 Expired | 2025-12-17 12:19 pm | 2020-12-16 2025-12-15 | InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO | 250 | $0 | 14,050 (Direct) | View |
| 2025-12-15 Expired | 2025-12-17 12:17 pm | 2020-12-16 2025-12-15 | InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer | 60 | $0 | 7,445 (Direct) | View |
| 2025-12-15 Expired | 2025-12-17 12:16 pm | 2020-12-16 2025-12-15 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 70 | $0 | 5,280 (Direct) | View |
Ownership | 2025-10-23 7:31 pm | N/A 2030-10-16 | InMed Pharmaceuticals Inc. | INM | Bathery John Steven Director | 0 | $0 | 3,500 (Direct) | View |
| 2025-10-17 Option Award | 2025-10-21 1:58 pm | N/A 2030-10-16 | InMed Pharmaceuticals Inc. | INM | Klompas Neil A Director | 3,500 | $0 | 3,500 (Direct) | View |
| 2025-01-11 Expired | 2025-02-03 08:49 am | 2020-01-12 2025-01-11 | InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director | 2 | $0 | 975 (Direct) | View |
| 2024-12-20 Option Award | 2024-12-23 09:28 am | N/A 2029-12-19 | InMed Pharmaceuticals Inc. | INM | Johnson Shane Aaron Sr VP & General Manager | 1,500 | $0 | 3,900 (Direct) | View |
| 2024-12-20 Option Award | 2024-12-23 09:26 am | N/A 2029-12-19 | InMed Pharmaceuticals Inc. | INM | Jagpal Netta Chief Financial Officer | 3,750 | $0 | 6,250 (Direct) | View |
| 2024-12-20 Option Award | 2024-12-23 09:25 am | N/A 2029-12-19 | InMed Pharmaceuticals Inc. | INM | Lemerond Nicole Director | 550 | $0 | 975 (Direct) | View |
| 2024-12-20 Option Award | 2024-12-23 09:24 am | N/A 2029-12-19 | InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer | 3,750 | $0 | 7,505 (Direct) | View |
| 2024-12-20 Option Award | 2024-12-23 09:22 am | N/A 2029-12-19 | InMed Pharmaceuticals Inc. | INM | Grove Janet P Director | 550 | $0 | 975 (Direct) | View |
| 2024-12-20 Option Award | 2024-12-23 09:21 am | N/A 2029-12-19 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 2,750 | $0 | 5,350 (Direct) | View |
| 2024-12-20 Option Award | 2024-12-23 09:20 am | N/A 2029-12-19 | InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO | 6,250 | $0 | 14,300 (Direct) | View |
| 2024-12-20 Option Award | 2024-12-23 09:18 am | N/A 2029-12-19 | InMed Pharmaceuticals Inc. | INM | Baldasare Bryan T Director | 550 | $0 | 975 (Direct) | View |
| 2024-12-20 Option Award | 2024-12-23 09:17 am | N/A 2029-12-19 | InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director | 550 | $0 | 977 (Direct) | View |
| 2024-05-27 Expired | 2024-05-28 4:27 pm | 2019-05-27 2024-05-27 | InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer | 394 | $0 | 75,100 (Direct) | View |
| 2024-05-27 Expired | 2024-05-28 4:26 pm | 2019-05-27 2024-05-27 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 545 | $0 | 52,000 (Direct) | View |
| 2024-05-27 Expired | 2024-05-28 4:26 pm | 2019-05-27 2024-05-27 | InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO | 1,139 | $0 | 161,000 (Direct) | View |
| 2024-05-27 Expired | 2024-05-28 4:26 pm | 2019-05-27 2024-05-27 | InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | 485 | $0 | 52,000 (Direct) | View |
| 2024-01-14 Expired | 2024-03-05 3:20 pm | 2019-01-14 2024-01-14 | InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director | 42 | $0 | 8,542 (Direct) | View |
| 2024-03-04 Expired | 2024-03-05 3:20 pm | 2019-03-04 2024-03-04 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 309 | $0 | 52,545 (Direct) | View |